Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A

References

• Angell YL, Burgess K. Peptidomimetics via copper-catalyzed azide–alkyne cycloadditions. Chem Soc Rev 2007;36:1674–89.
   PubMed Web of Science ®Google Scholar
• Kharb R, Sharma PC, Yar MS, et al. Pharmacological significance of triazole scaffold. J Enzyme Inhib Med Chem 2011;26:1–21.
   PubMed Web of Science ®Google Scholar
• Schulze B, Schubert US. Beyond click chemistry-supramolecular interactions of 1,2,3-triazoles. Chem Soc Rev 2014;43:2522–71.
   PubMed Web of Science ®Google Scholar
• Palmer MH, Parsons S. 4-Methyl-1,2,4-Triazole and 1-Methyl-Tetrazole. Acta Crystallogr Sect C Cryst Struct Commun 1996;52:2818–22.
   Google Scholar
• Sheremet EA, Tomanov RI, Trukhin EV, Berestovitskaya VM. Synthesis of 4-aryl-5-nitro-1,2,3-triazoles. Russ J Org Chem 2004;40:594–5.
   Web of Science ®Google Scholar
• Hafez HN, Abbas HAS, El-Gazzar ARBA. Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines. Acta Pharm 2008;58:359–78.
   PubMed Web of Science ®Google Scholar
• Liu K, Shi W, Cheng P. The coordination chemistry of Zn(II), Cd(II) and Hg(II) complexes with 1,2,4-triazole derivatives. Dalton Trans 2011;40:8475–90.
   PubMed Web of Science ®Google Scholar
• Passannanti A, Diana P, Barraja P, et al. Pyrrolo[2,3-d][1,2,3]triazoles as potential antineoplastic agents. Heterocycles 1998;48:1229–35.
   Web of Science ®Google Scholar
• Johns BA, Weatherhead JG, Allen SH, et al. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: establishing the pharmacophore. Bioorg Med Chem Lett 2009;19:1802–6.
   PubMed Web of Science ®Google Scholar
• Shalini K, Kumar N, Drabu S, Sharma PK. Advances in synthetic approach to and antifungal activity of triazoles. Beilstein J Org Chem 2011;7:668–77.
   PubMed Web of Science ®Google Scholar
• Lindstedt R, Ruggiero V, Alessio VD, et al. Inhibits T cell activation by reducing Nfat nuclear residency. Int J Immunopathol Pharmacol 2009;22:29–42.
   PubMed Web of Science ®Google Scholar
• Pacifico R, Destro D, Gillick-Healy MW, et al. Preparation of Acidic 5-Hydroxy-1,2,3-triazoles via the Cycloaddition of Aryl Azides with β-Ketoesters. J Org Chem 2021;86:11354–60.
   PubMed Web of Science ®Google Scholar
• Hamada Y. Role of pyridines in medicinal chemistry and design of BACE1 inhibitors possessing a pyridine scaffold. In: Pandey PP, ed. Pyridine. London, UK: IntechOpen; 2018. DOI:10.5772/intechopen.74719
   Google Scholar
• Asif M. Biological potential and chemical properties of pyridine and piperidine fused pyridazine compounds: pyridopyridazine a versatile nucleus. Asian J Pharm Sci 2016;1:29.
   Google Scholar
• Nobeli I, Price SL, Lommerse JPM, Taylor R. Hydrogen bonding properties of oxygen and nitrogen acceptors in aromatic heterocycles. J Comput Chem 1997;18:2060–74.
   Web of Science ®Google Scholar
• Laurence C, Brameld KA, Graton J, et al. The pKBHX database: toward a better understanding of hydrogen-bond basicity for medicinal chemists. J Med Chem 2009;52:4073–86.
   PubMed Web of Science ®Google Scholar
• Kenny PW, Montanari CA, Prokopczyk IM, et al. Hydrogen bond basicity prediction for medicinal chemistry design. J Med Chem 2016;59:4278–88.
   PubMed Web of Science ®Google Scholar
• Eicher T, Hauptmann S, Speicher A. The chemistry of heterocycles: structures, reactions, synthesis, and applications. Weinheim, Germany: John Wiley & Sons; 2013.
   Google Scholar
• Arnold DS, Plank CA, Erickson EE, Pike FP. Solubility of benzene in water. J Chem Eng Data 1958;3:253–6.
   Google Scholar
• Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 2000;43:3714–7.
   PubMed Web of Science ®Google Scholar
• Hohenstein EG, Sherrill CD. Effects of heteroatoms on aromatic π-π interactions: benzene-pyridine and pyridine dimer. J Phys Chem A 2009;113:878–86.
   PubMed Web of Science ®Google Scholar
• Huber RG, Margreiter MA, Fuchs JE, et al. Heteroaromatic π-stacking energy landscapes. J Chem Inf Model 2014;54:1371–9.
   PubMed Web of Science ®Google Scholar
• Vitaku E, Smith DT, Njardarson JT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J Med Chem 2014;57:10257–74.
   PubMed Web of Science ®Google Scholar
• Hsu KHK. Thirty years after isoniazid: its impact on tuberculosis in children and adolescents. JAMA 1984;251:1283–5.
   PubMed Web of Science ®Google Scholar
• Pym AS, Domenech P, Honoré N, et al. Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. Mol. Microbiol 2001;40:879–89.
   PubMed Web of Science ®Google Scholar
• Morlock GP, Metchock B, Sikes D, et al. ethA, inhA, and katG Loci of ethionamide-resistant clinical mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2003;47:3799–805.
   PubMed Web of Science ®Google Scholar
• Wang Z, Vince R. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine. Bioorg Med Chem 2008;16:3587–95.
   PubMed Web of Science ®Google Scholar
• Wang L, Kumar R, Pavlov PF, Winblad B. Small molecule therapeutics for tauopathy in Alzheimer’s disease: walking on the path of most resistance. Eur J Med Chem 2021;209:112915.
   PubMed Web of Science ®Google Scholar
• Minami J, Numabe A, Andoh N, et al. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension. Br J Clin Pharmacol 2004;57:632–9.
   PubMed Web of Science ®Google Scholar
• Wang JG, Kario K, Lau T, et al. Asian Pacific Heart Association. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association. Hypertens Res 2011;34:423–30.
   PubMed Web of Science ®Google Scholar
• Voss AK, Thomas T. Histone lysine and genomic targets of histone acetyltransferases in mammals. BioEssays 2018;40:1800078–16.
   Web of Science ®Google Scholar
• Ud-Din AIMS, Tikhomirova A, Roujeinikova A. Structure and functional diversity of GCN5-related n-acetyltransferases (GNAT). Int J Mol Sci 2016;17:1018.
   PubMed Web of Science ®Google Scholar
• Smith BC, Denu JM. Chemical mechanisms of histone lysine and arginine modifications. Biochim Biophys Acta Gene Regul Mech 2009;1789:45–57.
   PubMed Web of Science ®Google Scholar
• Chen L, Wei T, Si X, et al. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression. J Biol Chem 2013;288:14510–21.
   PubMed Web of Science ®Google Scholar
• Yin YW, Jin HJ, Zhao W, et al. The histone acetyltransferase GCN5 expression is elevated and regulated by c-Myc and E2F1 transcription factors in human colon cancer. Gene Expr 2015;16:187–96.
   PubMed Web of Science ®Google Scholar
• Dekker FJ, Van Den Bosch T, Martin NI. Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases. Drug Discov Today 2014;19:654–60.
   PubMed Web of Science ®Google Scholar
• Sun C, Wang M, Liu X, et al. PCAF improves glucose homeostasis by suppressing the gluconeogenic activity of PGC-1α. Cell Reports 2014;9:2250–62.
   PubMed Web of Science ®Google Scholar
• Balasubramanyam K, Swaminathan V, Ranganathan A, Kundu TK. Small molecule modulators of histone acetyltransferase p300. J Biol Chem 2003;278:19134–40.
   PubMed Web of Science ®Google Scholar
• Arif M, Pradhan SK, Thanuja GR, et al. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules. J Med Chem 2009;52:267–77.
   PubMed Web of Science ®Google Scholar
• Balasubramanyam K, Altaf M, Varier RA, et al. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 2004;279:33716–26.
   PubMed Web of Science ®Google Scholar
• Balasubramanyam K, Varier RA, Altaf M, et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004;279:51163–71.
   PubMed Web of Science ®Google Scholar
• Chimenti F, Bizzarri B, Maccioni E, et al. Novel histone acetyltransferase inhibitor modulating Gcn5 network: cyclopentylidene-[4-(4’ chlorophenyl)thiazol-2-yl)hydrazone. J Med Chem 2009;52:530–6.
   PubMed Web of Science ®Google Scholar
• Ghizzoni M, Haisma HJ, Dekker FJ. Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase. Eur J Med Chem 2009;44:4855–61.
   PubMed Web of Science ®Google Scholar
• Alvarez-Sánchez R, Basketter D, Pease C, Lepoittevin JP. Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol. Chem Res Toxicol 2003;16:627–36.
   PubMed Web of Science ®Google Scholar
• Furdas SD, Shekfeh S, Bissinger EM, et al. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors. Bioorg Med Chem 2011;19:3678–89.
   PubMed Web of Science ®Google Scholar
• Siragusa L, Cross S, Baroni M, et al. BioGPS: navigating biological space to predict polypharmacology, off-targeting, and selectivity. Proteins 2015;83:517–32.
   PubMed Web of Science ®Google Scholar
• Baroni M, Cruciani G, Sciabola S, et al. A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application. J Chem Inf Model 2007;47:279–94.
   PubMed Web of Science ®Google Scholar
• Davies JP, Cotter PD, Ioannou YA. Cloning and mapping of human Rab7 and Rab9 cDNA sequences and identification of a Rab9 pseudogene. Genomics 1997;41:131–4.
   PubMed Web of Science ®Google Scholar
• Hinds TD, Sánchez ER. Protein phosphatase 5. Int J Biochem Cell Biol 2008;40:2358–62.
   PubMed Web of Science ®Google Scholar
• Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes. Angew Chem Int Ed 2002;41:2596–9.
   PubMed Web of Science ®Google Scholar
• Chaganti LK, Venkatakrishnan N, Bose K. An efficient method for FITC labelling of proteins using tandem affinity purification. Biosci Rep 2018;38:1–8.
   Web of Science ®Google Scholar
• https://westbioscience.com/acetyltransferase/assay-kit/gcn5-fluorogenic-assay-kit-3372.html
   Google Scholar
• Kikuchi H, Kuribayashi F, Kiwaki N, et al. GCN5 regulates the superoxide-generating system in leukocytes via controlling Gp91-phox gene expression. J Immunol 2011;186:3015–22.
   PubMed Web of Science ®Google Scholar